Loading company…
Qi Biodesign develops gene editing technology and applications for plant breeding.
Founded in 2021 and based in Suzhou, China, Qi Biodesign develops gene editing technologies for plant breeding and has built its SEEDIT™ trait engineering platform. The platform supports gene and genome operations across more than 40 crops. In May 2026, the company raised over CNY 100 million in Series A+ funding led by CITIC Agriculture, with participation from Confitop Capital, Construction Future Fund, Nanjing Innovation Capital Group and Starbucks Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in